Trivant Custom Portfolio Group, LLC Moderna, Inc. Transaction History
Trivant Custom Portfolio Group, LLC
- $173 Billion
- Q3 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 120 shares of MRNA stock, worth $6,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120Holding current value
$6,424% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
1,036Shares Held
242MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO42.5MShares$2.27 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.12 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.37 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$804 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$387 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $20.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...